Trials / Unknown
UnknownNCT05141422
A Drug-drug Interaction Study of SHR2150 on Healthy Chinese Volunteers
A Single-centre, Single-arm, Open-label and Fixed-sequence Drug-drug Interaction Study to Evaluate the Effect of Efavirenz on the Pharmacokinetics of SHR2150 in Healthy Chinese Subjects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The study is a single-centre, open-label, fixed-sequence, self-controlled clinical trial. It is planned to enroll 20 healthy adult subjects. Subjects will take SHR2150 on Day 1 and Day 21, and take efavirenz from Day 7 to Day 26.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR2150 tablet、efavirenz | SHR2150 tablet single dose, Efavirenz single dose. |
Timeline
- Start date
- 2021-12-13
- Primary completion
- 2022-01-15
- Completion
- 2022-01-22
- First posted
- 2021-12-02
- Last updated
- 2021-12-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05141422. Inclusion in this directory is not an endorsement.